A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis

Medical Science Monitor

Volumn 14, Issue 3, 2008, Pages

  Salari, Pooneh ^a   Rezaie, Ali ^b   Larijani, Bagher ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bone health; n 3 fatty acids; n 6 fatty acids; Osteoporosis

Indexed keywords

CALCIUM; CASEIN; CORN OIL; DEOXYPYRIDINOLINE; DIHOMOGAMMALINOLENIC ACID; DOCOSAHEXAENOIC ACID; EFACAL; ESTROGEN; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; ISOFLAVONE; LINOLEIC ACID; LINOLENIC ACID; LINSEED OIL; MENHADEN OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PLACEBO; POLYUNSATURATED FATTY ACID; PRIMROSE OIL; REACTIVE OXYGEN METABOLITE; SOYBEAN PROTEIN; SUNFLOWER OIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BONE ATROPHY; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CALCIUM BONE LEVEL; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; HUMAN; INFLAMMATION; LIPID METABOLISM; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; SYSTEMATIC REVIEW;

ANIMALS; BONE DENSITY; BONE RESORPTION; DIETARY FATS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 41449115521     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. NIH Consensus Development Panel on Osteoporosis. JAMA, 2000; 785-95
2. Nevitt MC: Epidemiology of osteoporosis. Rheum dis Clin North Am, 1994; 20(3): 535-59
3. Larijani B, Moayyeri A, Keshtkar AA et al: Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis study. J Clin Densitom, 2006; 9(3): 367-74
4. McGarry KA, Kiel DP: Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med, 2000; 108(3): 79-82, 85-88, 91
5. Cauley JA, Thompson DE, Ensrud KC et al: Risk of mortality following clinical fractures. Osteoporosis Int, 2000; 11(7): 556-61
6. Ray NF, Chan JK, Thamer M, Melton LJ III: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the national osteoporosis foundation. J Bone Miner Res, 1997; 12(1): 24-35
7. st century. Am J Med, 1997; 103(2A): 20S-25S; discussion 25S-26S
8. Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporosis Int, 2005; 16(Suppl.2): S3-7
9. Johnell O, Kanis JA, Jonsson B et al: The burden of hospitalized fractures in Sweden. Osteoporosis Int, 2005; 16: 222-28
10. MacKelvie KJ, Khan KM, McKay HA: Is there a critical period for bone response to weight-bearing exercise in children and adolescents? A systematic review. Br J Sports Med, 2002; 36: 250-57
11. Nordstrom A, Karlsson C, Nyquist F et al: Bone loss and fracture risk after reduced physical activity. J Bone Miner Res, 2005; 20: 202-27
12. Nordstrom A, Olsson T, Nordstrom P: Sustained benefits from previous physical activity on bone mineral density in males. J Clin Endocrinol Metab, 2006; 91: 2600-4
13. Eisman JA: Genetics of osteoporosis. Endocr Rev, 1999; 20: 788-804
14. Seeman E, Hopper JL, Bach LA et al: Reduced bone mass in daughters of women with osteoporosis. N Eng J Med, 1989; 320: 554-58
15. Bauer J: Bemerkungen zur Frage der Osteoporosis. Wien Klin Wochenschr, 1963; 75: 691-92
16. Parfitt AM: Quantum concept of bone remodelling and turnover implications for the pathogenesis of osteoporosis. Calcif Tissue Int, 1997; 28: 1-5
17. Jimi E, Akiyama S, Tsurukai T et al: Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol, 1999; 163: 434-42
18. Abdollahi M, Larijani B, Rahimi R, Salari P: Role of oxidative stress in osteoporosis. Therapy, 2005; 2(5): 787-96
19. Yousefzadeh G, Larijani B, Mohammadirad A et al: Determination of oxidative stress status and concentration of tgf-β1 in the blood and saliva of osteoporotic subjects. Annals of New York Academy of Science, 2006; 1091: 142-50
20. Rezaie A, Parker RD, Abdollahi M: Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci, 2007; 52: 2015-21
21. Garrett IR, Boyce BF, Oreffo RO et al: Oxygen- derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest, 1990; 85(3): 632-39
22. Suda N, Morita I, Kuroda T, Murota S: Participation of oxidative stress in the process of osteoclast differentiation. Biochem Biophys Acta, 1993; 1157(3): 318-23
23. Watkins BA, Lippman HE, Le Bouteiller L et al: Bioactive fatty acids: role in bone biology and bone cell function. Progress Lipid Res, 2001; 40(1-2): 125-48
24. Speizer LA, Watson MJ, Brunton LL: Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am J Physiol, 1991; 261(1 Pt 1): E109-14
25. Cleland LG, James MJ, Neumann MA et al: Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr, 1992; 55(2): 395-99
26. Meydani SN, Lichtenstein AH, Cormwall S et al: Immunologic effects of national cholesterol education panel step- 2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest, 1993; 92(1): 105-13
27. Caughey GE, Mantzioris E, Gibson RA et al: The effect on human TNF-α and IL-1b production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr, 1996; 63(1): 116-22
28. Das UN: Essential fatty acids and osteoporosis. Nutrition, 2000; 16(5): 386-90
29. Horowitz MC: Cytokines and estrogen in bone: anti-osteoporotic effects. Science, 1993; 260(5108): 626-27
30. Votta BJ, Bertolini DR: Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro. Bone, 1994; 15(5): 533-38
31. Claassen N, Coetzer H, Steinmann CM, Kruger MC: The effects of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids, 1995; 53(1): 13-19
32. Hay AW, Hassam AG, Crawford M et al: Essential fatty acid restriction inhibits vitamin D-dependent calcium absorption. Lipids, 1980; 15(4): 251-54
33. Sakaguchi K, Morita I, Murota S: Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids, 1994; 50(2): 81-84
34. Kruger M, Claassen N, Smuts C, Potgeiter HC: Correlation between essential fatty acids and parameters of bone formation and degradation. Asia Pacific J Clin Nutr, 1997; 6: 235-38
35. Schlemmer CK, Coetzer H, Claassen N, Kruger MC: Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandsins Leukot essent Fatty Acids, 1999; 61(6): 381-90
36. Sun D, Krishnan A, Zaman K et al: Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res, 2003; 18(7): 1206-16
37. 2 biosynthesis, tissue IGF-I levels and bone morphometry in chicks. J Bone Miner Res, 1996; 11(9): 1321-32
38. 2 production, IGF-I concentration and formation rate in chicks. J Nutr, 1997; 127(6): 1084-91
39. Alam SQ, Kokkins PP, Alam BS: Fatty acid composition and arachidonic acid concentrations in alveolar bone of rats fed diets with different lipids. Calcif Tissue Int, 1993; 53(5): 330-32
40. Watkins BA, Reinwald S, Li Y, Seifert MF: Protective actions of soyisoflavones and n-3 PUFASs on bone mass in ovariectomized rats. J Nutr Biochem, 2005; 16(8): 479-88
41. Mollard RC, Gillam ME, Wood TM et al: (n-3) Fatty acids reduce the release of PGE2 from bone but do not affect bone mass in obese (fa/ fa) and lean Zucker rats. J Nutr, 2005; 135(3): 499-504
42. Yong L, Seifert MF, Ney DM et al: Dietary conjugated linoleic acid alter serum IGF-I and IGF binding protein concentration and reduce bone formation in rat fed (n-6) or (n-3) fatty acids. J Bone Mineral Res, 1999; 14: 1153-62
43. Shen CL, Yeh JK, Rasty J et al: Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. British J Nutr, 2006; 95: 462-68
44. Shen CL, Yeh JK, Rasty J, Chyy MC et al: Improvement of bone quality in gonad-intact middle-aged male rats by long-chain n-3 polyunsaturated fatty acid. Calcif Tis Int, 2007; 80(4): 286-93
45. Watkins BA, Li Y, Seifert MF: Dietary ratio of n-6/n-3 PUFAs and DHA: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem, 2006; 17(4): 282-89
46. Mollard RC, Kovacs HR, Fitzpatrick-Wong SC, Weiler HA: Low levels of dietary arachidonic and docosahexaenoic acids improve bone mass in neonatal piglets, but higher levels provide no benefit. J Nutr, 2005; 135(3): 505-12
47. Claassen N, Potgieter HC, Seppa M et al: Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone, 1995; 16(Suppl.4): 385S-392S
48. Sun L, Tamaki H, Ishimaru T et al: Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat. Biosci Biotechnol Biochem, 2004; 68(12): 2613-15
49. Judex S, Whol GR, Wolff RB et al: Dietary fish oil supplementation adversely affects cortical bone morphology and biomechanics in growing rabbits. Calc Tissue Int, 2000; 66(6): 443-48
50. Raewyn C, Poulsen M, Kruger C: Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins, Leuk and essential fatty acids, 2006; 75: 419-27
51. Cooper C, Atkinson EJ, Hensrud DD et al: Dietary protein intake and bone mass in women. Calcif Tissue Int, 1996; 58(5): 320-25
52. Kato I, Toniolo P, Zeleniuch-Jacquotte A et al: Diet smoking, and anthropometric indices and postmenopausal bone fractures: a prospective study. Int J Epidemiol, 2000; 29(1): 85-92
53. Michaelsson K, Holmberg L, Mallmin H et al: Diet, bone mass and osteocalcin: a cross-sectional study. Calcif Tissue Int, 1995; 57(2): 86-93
54. Van Papendrop DH, Coetzer H, Kruger MG: Biochemical profile of osteoporotic patients on essential fatty acids supplementation. Nutr Res, 1995; 15: 325-34
55. Kruger MC, Coetzer H, de Winter R et al: Calcium, gammalinolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res, 1998; 10(5): 385-94
56. Bassey EJ, Lettlewood JE, Rothwell MC, Pye DW: Lack of effects of supplementation with essential fatty acids on bone mineral density in healthy pre and postmenopausal women: two randomised controlled trial of Efacal® v calcium alone. Br J Nutr, 2000; 83(6): 629-35
57. Macdonald HM, New SA, Golden MH et al: Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr, 2004; 79(1): 155-65
58. Corwin RL, Hartman TJ, Maczuga SA, Graubard BI: Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III. J Nutr, 2006; 136: 159-65
59. Griel AE, Kris-Etherton PM, Hilpert KF et al: Dietary omega-3 fatty acids reduce bone resorption in humans. FASEB J, 2004; 18(5): A921 Suppl
60. Trichopoulos A, Georgiou E, Bassiakos Y et al: Energy intake and monounsaturated fat in relation to bone mineral density among women and men in Greece. Prev Med, 1997; 26: 395-400
61. Weiss LA, Barrett-Connor E, von Muhlen D: Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr, 2005; 81(4): 934-38
62. 2 Study. Am J Clin Nutr, 2007; 85: 803-7
63. Griel AE, Kris-Etherton PM, Kirsten FH et al: An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J, 2007; 6: 2
64. Harris WS: N-3 fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr, 1997; 65(Suppl.5): 1611S-16S
65. Wohl GR, Loehrke L, Watkins BA, Zernicke RF: Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int, 1998; 63(1): 74-79
66. Rahimi R, Nikfar S, Larijani B, Abdollahi M: A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacoth, 2005; 59(7): 365-73
67. Yousefzadeh G, Larijani B, Mohammadirad A et al: Determination of oxidative stress status and concentration of TGF-β1 in the blood and saliva of osteoporotic subjects. Ann NY Acad Sci, 2006; 1091: 142-50
68. Jin GB, Inoue S, Urano T et al: Induction of anti-metallothionein antibody and mercury treatment decreases bone mineral density in mice. Toxicol Appl Pharmacol, 2002; 185: 98-110
69. Matsuo N: Studies on the toxicity of fish oil V toxicity of oxidized commercial cod-liver oil. Tokushima J Exp Med., 1961; 8: 96-100
70. Nair PP, Judd JT, Berlin E et al: Dietary fish oil-induced changes in the distribution of alpha-tocopherol, retinol, and beta-carotene in plasma, red blood cells, and platelets: modulation by vitamin E. Am J Clin Nutr, 1993; 58: 98-102
71. Abdollahi M, Ranjbar A, Shadnia S et al: Pesticides and oxidative stress: a review. Med Sci Monit, 2004; 10(6): RA141-47